USP7 promotes immune suppression by stabilizing checkpoint molecules such as PD-L1, modulating FGL1/LAG-3 signaling, reshaping tumor-associated macrophage polarization, and reinforcing T-cell dysfunction. The gene discussed is FGL1; the disease is neoplasm.